At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,308 enrolled
Drug / intervention
Fentanyldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Matrifen® in Patients Older Than 18 Years With Severe, Chronic Pain Including Quality of Life Questionnaire
In Brief
An observational study evaluating Fentanyl for Severe Chronic Pain. Completed, enrolled 5,308 participants across 1,235 sites.
Detailed Summary
The aim of the study was to evaluate the efficacy and safety of Matrifen® in patients with severe and chronic pain who could only be sufficiently treated with opioid analgetics (WHO class 3).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Chronic Pain
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
First PostedJun 2008
Primary CompletionJul 2009
TodayJul 2026
First PostedJun 18, 2008
Enrollment StartJun 1, 2008
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 18.0 years ago
Interventions
Fentanyldrug
Fentanyl transdermal patch. This was an observational study - therefore, the physician decided about dosage according to individual needs